Melanoma skin cancer vaccine being trialled on NHS halves risk of death or relapse; Pioneering technology gives patients personalised treatment in combination with immunotherapy drug pembrolizumab

Byline: Michael Searles, Health Correspondent in in Chicago A vaccine being trialled on the NHS for melanoma skin cancer has been found to halve the risk of death or relapse. [...]